Age should not be a bar to thrombolytic therapy

Thrombolytic treatment for stroke is effective in elderly patients and advice against treating this group should be reviewed, research suggests.

Patients aged above 80 are often thought to have poor prognoses (Photograph: SPL)
Patients aged above 80 are often thought to have poor prognoses (Photograph: SPL)

Despite fears of poor prognosis in patients aged over 80 years, researchers found that treatment improves outcomes, regardless of age.

The findings suggest that age alone should not be a barrier to treatment.

The researchers, led by Nishant Mishra at the University of Glasgow, examined the effectiveness of thrombolysis treatment in stroke patients of all ages.

Thrombolysis is thought to be associated with poorer prognosis in older people, with greater risk for haemorrhage and hospital mortality.

As a result, the European Medicines Agency has not approved thrombolysis with alteplase for patients above 80 years old.

To test whether age affects the effectiveness and safety of the treatment, researchers analysed data from 29,228 stroke patients.

These patients had received either thrombolysis with IV alteplase or no treatment.

In total, 3,439 of the patients were aged over 80. Disability was measured using the modified Rankin scale at baseline and at 90 days after treatment.

Patients of all ages who underwent thrombolysis experienced improved outcomes.

The odds of improved outcomes attenuated slightly in patients aged above 80 years but thrombolytic therapy remained more effective than no treatment in this group.

The authors said that the weight of evidence to date indicated a potential for benefit in older people.

'We conclude that clinical treatment guidelines should be revised to remove the age restriction in use of IV alteplase for acute ischaemic stroke,' they said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

The proportion of NHS GPs trained in the EEA has stabilised after a steady decline...

GPs split on calls to suspend appraisal for duration of pandemic

GPs split on calls to suspend appraisal for duration of pandemic

Senior GPs are divided over calls for appraisal to be halted for the rest of the...

GP fears rising over covert recording of consultations in pandemic

GP fears rising over covert recording of consultations in pandemic

Fears over patients covertly recording consultations have increased among GPs since...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...